The synergistic effect on cell growth inhibition was validated, and the combination of AZD7648 and olaparib effectively increased the genomic instability.190 The IDH mutation has been an important target for acute myeloid leukemia (AML), which blocks AML cells’ differentiation. Here, IDH1 is linked to acute myeloid leukemia.